Zhejiang Orient Gene Biotech Co., Ltd, established in December 2005, is a company specialized in R&D, production and sales of in-vitro diagnostic products. Now, we have achieved the whole industry chain layout from the antigen antibodies and other biological raw materials to the in-vitro diagnostic reagents and in-vitro diagnostic instruments, which builds the business structure taking the POCT instant diagnostic reagent as the leading product and focusing on the development of molecular diagnosis, biological raw materials, POCT instruments, liquid biochips, and other products. 66 items have CFDA product certificates and recordation certificates, 31 items have FDA (510k) product certification, 225 items have European CE product certification, 67 items have Canadian MDL product certification, and 3 items have Mexican medical device product certification. Our products are exported to North America, Asia, Africa, Europe, South America, and Oceania, and we own customers in more than 100 countries around the world, and set up wholly-owned subsidiaries in the United States and Canada, accounting for about 95% of export sales. We are the rare domestic medical device manufacturer fully opening the overseas markets. Our sales volume was about 367,000,000 yuan RMB, and the profit was 82,000,000 yuan in 2019. We listed on the China’s Sci-Tech Innovation Board (STAR Market) on February 5th, 2020.
The POCT instant diagnostic reagent (colloidal gold method) is the main revenue and profit source of Orient Gene, and its sales volume accounts for about 98% of the Orient Gene’s main business income each year. The POCT instant diagnostic reagent refers to the diagnostic product making the clinical point-of-care testing without the complex treatment process in a laboratory.
The product is mainly used for the drug test, infectious disease test, fertility and postnatal care test, tumor marker test and cardiac marker test. Among them, the drug test and infectious disease test are the two core product series of Orient Gene, which contributes to the main business income, and the end customers include the Fortune Global 500 companies, such as Walmart, Dollar Tree, CVS, Walgreens, etc. For the infectious disease test, the HIV and HCV test kits have passed the highest-level European CE List A certification due to Orient Gene’s efficient R&D capability and good quality management system; Orient Gene obtained the financial assistance from Bill & Melinda Gates Foundation, which is specially used for the WHO pre-qualified of malaria test kits. The malaria (Pf/Pan) and malaria (Pf) test kits of Orient Gene passed the fifth round and seventh round evaluation of WHO respectively, and are expected to become the first Chinese company to obtain the WHO pre-qualified and promote the international pace of China’s in vitro diagnostics industry.
Гуанчжоу Склад 9-114, Tongda Creative Park, район Байюнь
Наш склад в Пекине:
B3 Floor, Chaowaimen, No. 26 Chaowai Street, Chaoyang District, Пекин
28-31 Merry Lane
East Hanover, NJ 07936